A Study to Evaluate the Veriton SPECT System

Overview

About this study

The purpose of this study is to determine if the Veriton SPECT system can achieve equal or better imaging quality than a standard SPECT system, while simultaneously reducing scan time.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • They are currently scheduled to undergo a nuclear medicine exam.
  • Age 18 years or older.

Exclusion Criteria:

  • They are unable to understand and sign the consent form.
  • Are unable to lie on the Veriton imaging table for up to 20 minutes.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michael O'Connor, Ph.D.

Contact us for the latest status

Contact information:

Kera Delaney CCRP

(507)422-6565

Delaney.Kera@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20502360

Mayo Clinic Footer